Year |
Citation |
Score |
2024 |
Eismann L, Ledderose ST, Enzinger B, Berg E, Westhofen T, Rodler S, Schulz GB, Toms J, Holzgreve A, Gildehaus FJ, Brendel M, Cyran CC, Unterrainer M, Stief CG, Bartenstein P, et al. [Ga]Ga-FAPI-46 PET/CT for penile cancer - a feasibility study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 38761187 DOI: 10.1007/s00259-024-06763-1 |
0.394 |
|
2024 |
Shojaei M, Zhou Q, Palumbo G, Schaefer R, Kaskinoro J, Vehmaan-Kreula P, Bartenstein P, Brendel M, Edbauer D, Lindner S. Development and Preclinical Evaluation of a Copper-64-Labeled Antibody Targeting Glycine-Alanine Dipeptides for PET Imaging of C9orf72-Associated Amyotrophic Lateral Sclerosis/Frontotemporal Dementia. Acs Pharmacology & Translational Science. 7: 1404-1414. PMID 38751620 DOI: 10.1021/acsptsci.4c00037 |
0.437 |
|
2024 |
Meindl M, Zatcepin A, Gnörich J, Scheifele M, Zaganjori M, Groß M, Lindner S, Schaefer R, Simmet M, Roemer S, Katzdobler S, Levin J, Höglinger G, Bischof AC, Barthel H, ... ... Brendel M, et al. Assessment of [F]PI-2620 Tau-PET Quantification via Non-Invasive Automatized Image Derived Input Function. European Journal of Nuclear Medicine and Molecular Imaging. PMID 38717592 DOI: 10.1007/s00259-024-06741-7 |
0.609 |
|
2024 |
Wang M, Lu J, Zhang Y, Zhang Q, Wang L, Wu P, Brendel M, Rominger A, Shi K, Zhao Q, Jiang J, Zuo C. Characterization of tau propagation pattern and cascading hypometabolism from functional connectivity in Alzheimer's disease. Human Brain Mapping. 45: e26689. PMID 38703095 DOI: 10.1002/hbm.26689 |
0.323 |
|
2024 |
Bischof GN, Brendel M, Barthel H, Theis H, Barbe M, Bartenstein P, Claasen J, Danek A, Höglinger G, Levin J, Marek K, Neumaier B, Palleis C, Patt M, Rullmann M, et al. Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [F]PI-2620. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 38575191 DOI: 10.2967/jnumed.123.265930 |
0.554 |
|
2024 |
Liubchenko G, Böning G, Zacherl M, Rumiantcev M, Unterrainer LM, Gildehaus FJ, Brendel M, Resch S, Bartenstein P, Ziegler SI, Delker A. Image-based dosimetry for [Ac]Ac-PSMA-I&T therapy and the effect of daughter-specific pharmacokinetics. European Journal of Nuclear Medicine and Molecular Imaging. PMID 38512484 DOI: 10.1007/s00259-024-06681-2 |
0.373 |
|
2024 |
Malpetti M, Franzmeier N, Brendel M. PET Imaging to Measure Neuroinflammation In Vivo. Methods in Molecular Biology (Clifton, N.J.). 2785: 177-193. PMID 38427195 DOI: 10.1007/978-1-0716-3774-6_12 |
0.394 |
|
2024 |
Ferschmann C, Messerschmidt K, Gnörich J, Barthel H, Marek K, Palleis C, Katzdobler S, Stockbauer A, Fietzek U, Finze A, Biechele G, Rumpf JJ, Saur D, Schroeter ML, Rullmann M, ... ... Brendel M, et al. Tau accumulation is associated with dopamine deficiency in vivo in four-repeat tauopathies. European Journal of Nuclear Medicine and Molecular Imaging. PMID 38366196 DOI: 10.1007/s00259-024-06637-6 |
0.503 |
|
2024 |
Biechele G, Rauchmann BS, Janowitz D, Buerger K, Franzmeier N, Weidinger E, Guersel S, Schuster S, Finze A, Harris S, Lindner S, Albert NL, Wetzel C, Rupprecht R, Rominger A, ... ... Brendel M, et al. Associations between sex, body mass index and the individual microglial response in Alzheimer's disease. Journal of Neuroinflammation. 21: 30. PMID 38263017 DOI: 10.1186/s12974-024-03020-y |
0.67 |
|
2024 |
Gold L, Barci E, Brendel M, Orth M, Cheng J, Kirchleitner SV, Bartos LM, Pötter D, Kirchner MA, Unterrainer LM, Kaiser L, Ziegler S, Weidner L, Riemenschneider MJ, Unterrainer M, et al. The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic Glioblastoma. Biomedicines. 12. PMID 38255293 DOI: 10.3390/biomedicines12010188 |
0.691 |
|
2024 |
Ruch F, Gnörich J, Wind K, Köhler M, Zatcepin A, Wiedemann T, Gildehaus FJ, Lindner S, Boening G, von Ungern-Sternberg B, Beyer L, Herms J, Bartenstein P, Brendel M, Eckenweber F. Validity and value of metabolic connectivity in mouse models of β-amyloid and tauopathy. Neuroimage. 286: 120513. PMID 38191101 DOI: 10.1016/j.neuroimage.2024.120513 |
0.66 |
|
2023 |
Palleis C, Franzmeier N, Weidinger E, Bernhardt AM, Katzdobler S, Wall S, Ferschmann C, Harris S, Schmitt J, Schuster S, Gnörich J, Finze A, Biechele G, Lindner S, Albert NL, ... ... Brendel M, et al. Association of Neurofilament Light Chain, [F]PI-2620 Tau-PET, TSPO-PET, and Clinical Progression in Patients With β-Amyloid-Negative CBS. Neurology. 102: e207901. PMID 38165362 DOI: 10.1212/WNL.0000000000207901 |
0.768 |
|
2023 |
Fraioli F, Albert N, Boellaard R, Galazzo IB, Brendel M, Buvat I, Castellaro M, Cecchin D, Fernandez PA, Guedj E, Hammers A, Kaplar Z, Morbelli S, Papp L, Shi K, et al. Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging. European Journal of Nuclear Medicine and Molecular Imaging. PMID 38097746 DOI: 10.1007/s00259-023-06553-1 |
0.503 |
|
2023 |
Bui VN, Unterrainer LM, Brendel M, Kunte SC, Holzgreve A, Allmendinger F, Bartenstein P, Klauschen F, Unterrainer M, Staehler M, Ledderose S. PSMA-Expression Is Highly Associated with Histological Subtypes of Renal Cell Carcinoma: Potential Implications for Theranostic Approaches. Biomedicines. 11. PMID 38002095 DOI: 10.3390/biomedicines11113095 |
0.34 |
|
2023 |
Stockbauer A, Beyer L, Huber M, Kreuzer A, Palleis C, Katzdobler S, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, ... ... Brendel M, et al. Metabolic network alterations as a supportive biomarker in dementia with Lewy bodies with preserved dopamine transmission. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37971501 DOI: 10.1007/s00259-023-06493-w |
0.466 |
|
2023 |
Blazhenets G, Soleimani-Meigooni DN, Thomas W, Mundada N, Brendel M, Vento S, VandeVrede L, Heuer HW, Ljubenkov P, Rojas JC, Chen MK, Amuiri AN, Miller Z, Gorno-Tempini ML, Miller BL, et al. [F]PI-2620 Binding Patterns in Patients with Suspected Alzheimer Disease and Frontotemporal Lobar Degeneration. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37918868 DOI: 10.2967/jnumed.123.265856 |
0.383 |
|
2023 |
Bartos LM, Kirchleitner SV, Kolabas ZI, Quach S, Beck A, Lorenz J, Blobner J, Mueller SA, Ulukaya S, Hoeher L, Horvath I, Wind-Mark K, Holzgreve A, Ruf VC, Gold L, ... ... Brendel M, et al. Deciphering sources of PET signals in the tumor microenvironment of glioblastoma at cellular resolution. Science Advances. 9: eadi8986. PMID 37889970 DOI: 10.1126/sciadv.adi8986 |
0.727 |
|
2023 |
Hong J, Lu J, Liu F, Wang M, Li X, Clement C, Lopes L, Brendel M, Rominger A, Yen TC, Guan Y, Tian M, Wang J, Zuo C, Shi K. Uncovering distinct progression patterns of tau deposition in progressive supranuclear palsy using [F]Florzolotau PET imaging and subtype/stage inference algorithm. Ebiomedicine. 97: 104835. PMID 37839135 DOI: 10.1016/j.ebiom.2023.104835 |
0.354 |
|
2023 |
Wang L, Xu H, Wang M, Brendel M, Rominger A, Shi K, Han Y, Jiang J. A metabolism-functional connectome sparse coupling method to reveal imaging markers for Alzheimer's disease based on simultaneous PET/MRI scans. Human Brain Mapping. PMID 37740923 DOI: 10.1002/hbm.26493 |
0.35 |
|
2023 |
Tolboom N, Verger A, Albert NL, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Herrmann K, Traub-Weidinger T, Morbelli S, Yakushev I, Zucchetta P, Barthel H, Van Weehaeghe D. EANM position paper: theranostics in brain tumours-the present and the future. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37698647 DOI: 10.1007/s00259-023-06425-8 |
0.47 |
|
2023 |
Weidner L, Lorenz J, Quach S, Braun FK, Rothhammer-Hampl T, Ammer LM, Vollmann-Zwerenz A, Bartos LM, Dekorsy FJ, Holzgreve A, Kirchleitner SV, Thon N, Greve T, Ruf V, Herms J, ... ... Brendel M, et al. Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages. Acta Neuropathologica Communications. 11: 147. PMID 37697350 DOI: 10.1186/s40478-023-01651-5 |
0.716 |
|
2023 |
Buchert R, Wegner F, Huppertz HJ, Berding G, Brendel M, Apostolova I, Buhmann C, Dierks A, Katzdobler S, Klietz M, Levin J, Mahmoudi N, Rinscheid A, Rogozinski S, Rumpf JJ, et al. Automatic covariance pattern analysis outperforms visual reading of F-fluorodeoxyglucose-positron emission tomography (FDG-PET) in variant progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 37655363 DOI: 10.1002/mds.29581 |
0.435 |
|
2023 |
Unterrainer M, Kunte SC, Unterrainer LM, Holzgreve A, Delker A, Lindner S, Beyer L, Brendel M, Kunz WG, Winkelmann M, Cyran CC, Ricke J, Jurkschat K, Wängler C, Wängler B, et al. Correction to: Next‑generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR‑targeting peptide [F]SiTATE. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37642707 DOI: 10.1007/s00259-023-06409-8 |
0.689 |
|
2023 |
Lu J, Clement C, Hong J, Wang M, Li X, Cavinato L, Yen TC, Jiao F, Wu P, Wu J, Ge J, Sun Y, Brendel M, Lopes L, Rominger A, et al. Improved interpretation of F-florzolotau PET in progressive supranuclear palsy using a normalization-free deep-learning classifier. Iscience. 26: 107426. PMID 37564702 DOI: 10.1016/j.isci.2023.107426 |
0.424 |
|
2023 |
Kolabas ZI, Kuemmerle LB, Perneczky R, Förstera B, Ulukaya S, Ali M, Kapoor S, Bartos LM, Büttner M, Caliskan OS, Rong Z, Mai H, Höher L, Jeridi D, Molbay M, ... ... Brendel M, et al. Distinct molecular profiles of skull bone marrow in health and neurological disorders. Cell. PMID 37562402 DOI: 10.1016/j.cell.2023.07.009 |
0.619 |
|
2023 |
Vogler L, Ballweg A, Bohr B, Briel N, Wind K, Antons M, Kunze LH, Gnörich J, Lindner S, Gildehaus FJ, Baumann K, Bartenstein P, Boening G, Ziegler SI, Levin J, ... ... Brendel M, et al. Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [F]UCB-H PET imaging. Neuroimage. Clinical. 39: 103484. PMID 37541098 DOI: 10.1016/j.nicl.2023.103484 |
0.7 |
|
2023 |
Albert NL, Nelwan DV, Fleischmann DF, Quach S, von Rohr K, Kaiser L, Teske N, Unterrainer LM, Bartos LM, Ruf VC, Brendel M, Riemenschneider MJ, Wetzel C, Herms J, Rupprecht R, et al. Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH-Wild-Type Glioblastoma. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37536737 DOI: 10.2967/jnumed.122.265247 |
0.746 |
|
2023 |
Palumbo G, Kunze LH, Oos R, Wind-Mark K, Lindner S, von Ungern-Sternberg B, Bartenstein P, Ziegler S, Brendel M. Longitudinal Studies on Alzheimer Disease Mouse Models with Multiple Tracer PET/CT: Application of Reduction and Refinement Principles in Daily Practice to Safeguard Animal Welfare during Progressive Aging. Animals : An Open Access Journal From Mdpi. 13. PMID 37531139 DOI: 10.3390/ani13111812 |
0.517 |
|
2023 |
Finze A, Biechele G, Rauchmann BS, Franzmeier N, Palleis C, Katzdobler S, Weidinger E, Guersel S, Schuster S, Harris S, Schmitt J, Beyer L, Gnörich J, Lindner S, Albert NL, ... ... Brendel M, et al. Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies. Molecular Psychiatry. PMID 37495886 DOI: 10.1038/s41380-023-02188-8 |
0.693 |
|
2023 |
Kunze LH, Ruch F, Biechele G, Eckenweber F, Wind-Mark K, Dinkel L, Feyen P, Bartenstein P, Ziegler S, Paeger L, Tahirovic S, Herms J, Brendel M. Long-Term Pioglitazone Treatment Has No Significant Impact on Microglial Activation and Tau Pathology in P301S Mice. International Journal of Molecular Sciences. 24. PMID 37373253 DOI: 10.3390/ijms241210106 |
0.636 |
|
2023 |
Unterrainer M, Kunte SC, Unterrainer LM, Holzgreve A, Delker A, Lindner S, Beyer L, Brendel M, Kunz WG, Winkelmann M, Cyran CC, Ricke J, Jurkschat K, Wängler C, Wängler B, et al. Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [F]SiTATE. European Journal of Nuclear Medicine and Molecular Imaging. PMID 37358620 DOI: 10.1007/s00259-023-06315-z |
0.707 |
|
2023 |
Koeglsperger T, Rumpf SL, Schließer P, Struebing FL, Brendel M, Levin J, Trenkwalder C, Höglinger GU, Herms J. Neuropathology of incidental Lewy body & prodromal Parkinson's disease. Molecular Neurodegeneration. 18: 32. PMID 37173733 DOI: 10.1186/s13024-023-00622-7 |
0.42 |
|
2023 |
Schönecker S, Palleis C, Franzmeier N, Katzdobler S, Ferschmann C, Schuster S, Finze A, Scheifele M, Prix C, Fietzek U, Weidinger E, Nübling G, Vöglein J, Patt M, Barthel H, ... ... Brendel M, et al. Symptomatology in 4-repeat tauopathies is associated with data-driven topology of [F]-PI-2620 tau-PET signal. Neuroimage. Clinical. 38: 103402. PMID 37087820 DOI: 10.1016/j.nicl.2023.103402 |
0.407 |
|
2023 |
Wischmann J, Bartos LM, Brendel M, Albert NL, Forbrig R, Straube A, Masouris I. Translocator protein (TSPO)-PET as diagnostic and monitoring tool in COVID-19 related MRI-negative brainstem encephalitis: a case report. Journal of Neurology. PMID 37012466 DOI: 10.1007/s00415-023-11691-5 |
0.512 |
|
2023 |
Ballweg A, Klaus C, Vogler L, Katzdobler S, Wind K, Zatcepin A, Ziegler SI, Secgin B, Eckenweber F, Bohr B, Bernhardt A, Fietzek U, Rauchmann BS, Stoecklein S, Quach S, ... ... Brendel M, et al. [F]F-DED PET imaging of reactive astrogliosis in neurodegenerative diseases: preclinical proof of concept and first-in-human data. Journal of Neuroinflammation. 20: 68. PMID 36906584 DOI: 10.1186/s12974-023-02749-2 |
0.776 |
|
2023 |
Verger A, Yakushev I, Albert NL, van Berckel B, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Morbelli S, Tolboom N, Traub-Weidinger T, Van Weehaeghe D, Barthel H. FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36869178 DOI: 10.1007/s00259-023-06177-5 |
0.642 |
|
2023 |
Gnörich J, Reifschneider A, Wind K, Zatcepin A, Kunte ST, Beumers P, Bartos LM, Wiedemann T, Grosch M, Xiang X, Fard MK, Ruch F, Werner G, Koehler M, Slemann L, ... ... Brendel M, et al. Depletion and activation of microglia impact metabolic connectivity of the mouse brain. Journal of Neuroinflammation. 20: 47. PMID 36829182 DOI: 10.1186/s12974-023-02735-8 |
0.746 |
|
2023 |
Eschbach RS, Hofmann M, Späth L, Sheikh GT, Delker A, Lindner S, Jurkschat K, Wängler C, Wängler B, Schirrmacher R, Tiling R, Brendel M, Wenter V, Dekorsy FJ, Zacherl MJ, et al. Comparison of somatostatin receptor expression in patients with neuroendocrine tumours with and without somatostatin analogue treatment imaged with [F]SiTATE. Frontiers in Oncology. 13: 992316. PMID 36793617 DOI: 10.3389/fonc.2023.992316 |
0.562 |
|
2023 |
Zounek AJ, Albert NL, Holzgreve A, Unterrainer M, Brosch-Lenz J, Lindner S, Bollenbacher A, Boening G, Rupprecht R, Brendel M, von Baumgarten L, Tonn JC, Bartenstein P, Ziegler S, Kaiser L. Feasibility of radiomic feature harmonization for pooling of [F]FET or [F]GE-180 PET images of gliomas. Zeitschrift Fur Medizinische Physik. PMID 36710156 DOI: 10.1016/j.zemedi.2022.12.005 |
0.668 |
|
2023 |
Zatcepin A, Kopczak A, Holzgreve A, Hein S, Schindler A, Duering M, Kaiser L, Lindner S, Schidlowski M, Bartenstein P, Albert N, Brendel M, Ziegler SI. Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patients. Zeitschrift Fur Medizinische Physik. PMID 36682921 DOI: 10.1016/j.zemedi.2022.11.008 |
0.625 |
|
2023 |
Palleis C, Forbrig R, Lehner L, Quach S, Albert NL, Brendel M, Schöberl F, Straube A. Lyme neuroborreliosis: An unusual case with extensive (peri)vasculitis of the middle cerebral artery. European Journal of Neurology. 30: 785-787. PMID 36636924 DOI: 10.1111/ene.15633 |
0.591 |
|
2023 |
van Lengerich B, Zhan L, Xia D, Chan D, Joy D, Park JI, Tatarakis D, Calvert M, Hummel S, Lianoglou S, Pizzo ME, Prorok R, Thomsen E, Bartos LM, Beumers P, ... ... Brendel M, et al. A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer's disease models. Nature Neuroscience. PMID 36635496 DOI: 10.1038/s41593-022-01240-0 |
0.466 |
|
2023 |
Delker A, Schleske M, Liubchenko G, Berg I, Zacherl MJ, Brendel M, Gildehaus FJ, Rumiantcev M, Resch S, Hürkamp K, Wenter V, Unterrainer LM, Bartenstein P, Ziegler SI, Beyer L, et al. Biodistribution and dosimetry for combined [Lu]Lu-PSMA-I&T/[Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36629878 DOI: 10.1007/s00259-022-06092-1 |
0.363 |
|
2023 |
Biel D, Suárez-Calvet M, Hager P, Rubinski A, Dewenter A, Steward A, Roemer S, Ewers M, Haass C, Brendel M, Franzmeier N. sTREM2 is associated with amyloid-related p-tau increases and glucose hypermetabolism in Alzheimer's disease. Embo Molecular Medicine. e16987. PMID 36620941 DOI: 10.15252/emmm.202216987 |
0.54 |
|
2022 |
Völter F, Beyer L, Eckenweber F, Scheifele M, Bui N, Patt M, Barthel H, Katzdobler S, Palleis C, Franzmeier N, Levin J, Perneczky R, Rauchmann BS, Sabri O, Hong J, ... ... Brendel M, et al. Assessment of perfusion deficit with early phases of [F]PI-2620 tau-PET versus [F]flutemetamol-amyloid-PET recordings. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36572740 DOI: 10.1007/s00259-022-06087-y |
0.618 |
|
2022 |
Quach S, Holzgreve A, Kaiser L, Unterrainer M, Dekorsy FJ, Nelwan DV, Bartos LM, Kirchleitner SV, Weller J, Weidner L, Niyazi M, Ruf VC, Herms J, Stöcklein S, Wetzel C, ... ... Brendel M, et al. TSPO PET signal using [F]GE180 is associated with survival in recurrent gliomas. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36329288 DOI: 10.1007/s00259-022-06006-1 |
0.74 |
|
2022 |
Bartos LM, Kirchleitner SV, Blobner J, Wind K, Kunze LH, Holzgreve A, Gold L, Zatcepin A, Kolabas ZI, Ulukaya S, Weidner L, Quach S, Messerer D, Bartenstein P, Tonn JC, ... ... Brendel M, et al. 18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model. Frontiers in Medicine. 9: 992993. PMID 36325388 DOI: 10.3389/fmed.2022.992993 |
0.675 |
|
2022 |
Fischer M, Zacherl MJ, Olivier J, Lindner S, Massberg S, Bartenstein P, Grawe F, Ziegler S, Brendel M, Lehner S, Boening G, Todica A. Detection of apoptosis by [F]ML-10 after cardiac ischemia-reperfusion injury in mice. Annals of Nuclear Medicine. PMID 36306025 DOI: 10.1007/s12149-022-01801-0 |
0.365 |
|
2022 |
Unterrainer LM, Todica A, Beyer L, Brendel M, Holzgreve A, Kauffmann-Guerrero D, Unterrainer M, Bartenstein P, Tufman A. Ga-EMP-100 PET/CT-a novel method for non-invasive assessment of c-MET expression in non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36253641 DOI: 10.1007/s00259-022-05995-3 |
0.411 |
|
2022 |
von Rohr K, Unterrainer M, Holzgreve A, Kirchner MA, Li Z, Unterrainer LM, Suchorska B, Brendel M, Tonn JC, Bartenstein P, Ziegler S, Albert NL, Kaiser L. Can Radiomics Provide Additional Information in [F]FET-Negative Gliomas? Cancers. 14. PMID 36230783 DOI: 10.3390/cancers14194860 |
0.667 |
|
2022 |
Katzdobler S, Nitschmann A, Barthel H, Bischof G, Beyer L, Marek K, Song M, Wagemann O, Palleis C, Weidinger E, Nack A, Fietzek U, Kurz C, Häckert J, Stapf T, ... ... Brendel M, et al. Additive value of [F]PI-2620 perfusion imaging in progressive supranuclear palsy and corticobasal syndrome. European Journal of Nuclear Medicine and Molecular Imaging. PMID 36102964 DOI: 10.1007/s00259-022-05964-w |
0.58 |
|
2022 |
Rauchmann BS, Brendel M, Franzmeier N, Trappmann L, Zaganjori M, Ersoezlue E, Morenas-Rodriguez E, Guersel S, Burow L, Kurz C, Haeckert J, Tatò M, Utecht J, Papazov B, Pogarell O, et al. Microglial Activation and Connectivity in Alzheimer Disease and Aging. Annals of Neurology. PMID 36053756 DOI: 10.1002/ana.26465 |
0.435 |
|
2022 |
Xiang X, Tahirovic S, Ziegler S, Haass C, Brendel M. Response to Comment on "Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases". Science Translational Medicine. 14: eabn5104. PMID 36001676 DOI: 10.1126/scitranslmed.abn5104 |
0.585 |
|
2022 |
Frontzkowski L, Ewers M, Brendel M, Biel D, Ossenkoppele R, Hager P, Steward A, Dewenter A, Römer S, Rubinski A, Buerger K, Janowitz D, Binette AP, Smith R, Strandberg O, et al. Earlier Alzheimer's disease onset is associated with tau pathology in brain hub regions and facilitated tau spreading. Nature Communications. 13: 4899. PMID 35987901 DOI: 10.1038/s41467-022-32592-7 |
0.325 |
|
2022 |
Blume T, Filser S, Sgobio C, Peters F, Neumann U, Shimshek D, Saito T, Saido TC, Brendel M, Herms J. β-secretase inhibition prevents structural spine plasticity deficits in mice. Frontiers in Aging Neuroscience. 14: 909586. PMID 35936777 DOI: 10.3389/fnagi.2022.909586 |
0.465 |
|
2022 |
Verger A, Barthel H, Tolboom N, Fraioli F, Cecchin D, Albert NL, van Berckel B, Boellaard R, Brendel M, Ekmekcioglu O, Semah F, Traub-Weidinger T, van de Weehaeghe D, Morbelli S, Guedj E. 2-[F]-FDG PET for imaging brain involvement in patients with long COVID: perspective of the EANM Neuroimaging Committee. European Journal of Nuclear Medicine and Molecular Imaging. PMID 35840817 DOI: 10.1007/s00259-022-05913-7 |
0.671 |
|
2022 |
Xia D, Lianoglou S, Sandmann T, Calvert M, Suh JH, Thomsen E, Dugas J, Pizzo ME, DeVos SL, Earr TK, Lin CC, Davis S, Ha C, Leung AW, Nguyen H, ... ... Brendel M, et al. Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia. Molecular Neurodegeneration. 17: 41. PMID 35690868 DOI: 10.1186/s13024-022-00547-7 |
0.44 |
|
2022 |
Unterrainer LM, Beyer L, Zacherl MJ, Gildehaus FJ, Todica A, Kunte SC, Holzgreve A, Sheikh GT, Herlemann A, Casuscelli J, Brendel M, Albert NL, Wenter V, Schmidt-Hegemann NS, Kunz WG, et al. Total Tumor Volume on F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with Ac-PSMA-I&T. Biomedicines. 10. PMID 35625683 DOI: 10.3390/biomedicines10050946 |
0.626 |
|
2022 |
Bartos LM, Kunte ST, Beumers P, Xiang X, Wind K, Ziegler S, Bartenstein P, Choi H, Lee DS, Haass C, von Baumgarten L, Tahirovic S, Albert NL, Lindner S, Brendel M. Single cell radiotracer allocation via immunomagentic sorting (scRadiotracing) to disentangle PET signals at cellular resolution. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35589403 DOI: 10.2967/jnumed.122.264171 |
0.762 |
|
2022 |
Holzgreve A, Pötter D, Brendel M, Orth M, Weidner L, Gold L, Kirchner MA, Bartos LM, Unterrainer LM, Unterrainer M, Steiger K, von Baumgarten L, Niyazi M, Belka C, Bartenstein P, et al. Longitudinal [F]GE-180 PET Imaging Facilitates In Vivo Monitoring of TSPO Expression in the GL261 Glioblastoma Mouse Model. Biomedicines. 10. PMID 35453488 DOI: 10.3390/biomedicines10040738 |
0.712 |
|
2022 |
Blume T, Deussing M, Biechele G, Peters F, Zott B, Schmidt C, Franzmeier N, Wind K, Eckenweber F, Sacher C, Shi Y, Ochs K, Kleinberger G, Xiang X, Focke C, ... ... Brendel M, et al. Chronic PPARγ Stimulation Shifts Amyloidosis to Higher Fibrillarity but Improves Cognition. Frontiers in Aging Neuroscience. 14: 854031. PMID 35431893 DOI: 10.3389/fnagi.2022.854031 |
0.667 |
|
2022 |
Messerschmidt K, Barthel H, Brendel M, Scherlach C, Hoffmann KT, Rauchmann BS, Rullmann M, Marek K, Villemagne VL, Rumpf JJ, Saur D, Schroeter ML, Schildan A, Patt M, Beyer L, et al. F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 35422444 DOI: 10.2967/jnumed.121.262854 |
0.709 |
|
2022 |
Antons M, Lindner M, Grosch M, Oos R, Palumbo G, Brendel M, Ziegler S, Bartenstein P, Dieterich M, Zwergal A. Longitudinal []UCB-H/[F]FDG imaging depicts complex patterns of structural and functional neuroplasticity following bilateral vestibular loss in the rat. Scientific Reports. 12: 6049. PMID 35411002 DOI: 10.1038/s41598-022-09936-w |
0.5 |
|
2022 |
Fischer M, Olivier J, Lindner S, Zacherl MJ, Massberg S, Bartenstein P, Ziegler S, Brendel M, Lehner S, Boening G, Todica A. Detection of cardiac apoptosis by [F]ML-10 in a mouse model of permanent LAD ligation. Molecular Imaging and Biology. PMID 35352214 DOI: 10.1007/s11307-022-01718-0 |
0.35 |
|
2022 |
Rullmann M, Brendel M, Schroeter ML, Saur D, Levin J, Perneczky RG, Tiepolt S, Patt M, Mueller A, Villemagne VL, Classen J, Stephens AW, Sabri O, Barthel H. Multicenter F-PI-2620 PET for In Vivo Braak Staging of Tau Pathology in Alzheimer's Disease. Biomolecules. 12. PMID 35327650 DOI: 10.3390/biom12030458 |
0.406 |
|
2022 |
Unterrainer LM, Lindner S, Eismann L, Casuscelli J, Gildehaus FJ, Bui VN, Albert NL, Holzgreve A, Beyer L, Todica A, Brendel M, Cyran CC, Karl A, Stief CG, Ledderose ST, et al. Feasibility of [Ga]Ga-FAPI-46 PET/CT for detection of nodal and hematogenous spread in high-grade urothelial carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. PMID 35325283 DOI: 10.1007/s00259-022-05761-5 |
0.637 |
|
2022 |
Franzmeier N, Brendel M, Beyer L, Slemann L, Kovacs GG, Arzberger T, Kurz C, Respondek G, Lukic MJ, Biel D, Rubinski A, Frontzkowski L, Hummel S, Müller A, Finze A, et al. Tau deposition patterns are associated with functional connectivity in primary tauopathies. Nature Communications. 13: 1362. PMID 35292638 DOI: 10.1038/s41467-022-28896-3 |
0.622 |
|
2022 |
Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, Brendel M, Cecchin D, Ekmekcioglu O, Garibotto V, Lammertsma AA, Law I, Peñuelas I, Semah F, Traub-Weidinger T, et al. Correction to: EANM procedure guidelines for brain PET imaging using [F]FDG, version 3. European Journal of Nuclear Medicine and Molecular Imaging. 49: 2100-2101. PMID 35254483 DOI: 10.1007/s00259-022-05755-3 |
0.662 |
|
2022 |
Shi Y, Cui M, Ochs K, Brendel M, Strübing FL, Briel N, Eckenweber F, Zou C, Banati RB, Liu GJ, Middleton RJ, Rupprecht R, Rudolph U, Zeilhofer HU, Rammes G, et al. Long-term diazepam treatment enhances microglial spine engulfment and impairs cognitive performance via the mitochondrial 18 kDa translocator protein (TSPO). Nature Neuroscience. 25: 317-329. PMID 35228700 DOI: 10.1038/s41593-022-01013-9 |
0.412 |
|
2022 |
Zatcepin A, Heindl S, Schillinger U, Kaiser L, Lindner S, Bartenstein P, Kopczak A, Liesz A, Brendel M, Ziegler SI. Reduced Acquisition Time [F]GE-180 PET Scanning Protocol Replaces Gold-Standard Dynamic Acquisition in a Mouse Ischemic Stroke Model. Frontiers in Medicine. 9: 830020. PMID 35223925 DOI: 10.3389/fmed.2022.830020 |
0.442 |
|
2022 |
Holzgreve A, Völter F, Delker A, Kunz WG, Fabritius MP, Brendel M, Albert NL, Bartenstein P, Unterrainer M, Unterrainer LM. Detection of Splenic Tissue Using Tc-Labelled Denatured Red Blood Cells Scintigraphy-A Quantitative Single Center Analysis. Diagnostics (Basel, Switzerland). 12. PMID 35204576 DOI: 10.3390/diagnostics12020486 |
0.556 |
|
2022 |
Schuster S, Beyer L, Palleis C, Harris S, Schmitt J, Weidinger E, Prix C, Bötzel K, Danek A, Rauchmann BS, Stöcklein S, Lindner S, Unterrainer M, Albert NL, Mittlmeier LM, ... ... Brendel M, et al. Impact of Partial Volume Correction on [F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome. Brain Sciences. 12. PMID 35203967 DOI: 10.3390/brainsci12020204 |
0.687 |
|
2022 |
Unterrainer M, Mahler C, Schumacher AM, Ruf V, Blum B, Quach S, Brendel M, Rupprecht R, Bartenstein P, Kerschensteiner M, Kümpfel T, Albert NL. Amino Acid Uptake, Glucose Metabolism, and Neuroinflammation in John Cunningham Virus Associated Progressive Multifocal Leukoencephalopathy. Clinical Nuclear Medicine. PMID 35195584 DOI: 10.1097/RLU.0000000000004093 |
0.711 |
|
2022 |
Finze A, Wahl H, Janowitz D, Buerger K, Linn J, Rominger A, Stöcklein S, Bartenstein P, Wollenweber FA, Catak C, Brendel M. Regional Associations of Cortical Superficial Siderosis and β-Amyloid-Positron-Emission-Tomography Positivity in Patients With Cerebral Amyloid Angiopathy. Frontiers in Aging Neuroscience. 13: 786143. PMID 35185518 DOI: 10.3389/fnagi.2021.786143 |
0.467 |
|
2022 |
Reifschneider A, Robinson S, van Lengerich B, Gnörich J, Logan T, Heindl S, Vogt MA, Weidinger E, Riedl L, Wind K, Zatcepin A, Pesämaa I, Haberl S, Nuscher B, Kleinberger G, ... ... Brendel M, et al. Loss of TREM2 rescues hyperactivation of microglia, but not lysosomal deficits and neurotoxicity in models of progranulin deficiency. The Embo Journal. e109108. PMID 35019161 DOI: 10.15252/embj.2021109108 |
0.416 |
|
2021 |
Kaiser L, Holzgreve A, Quach S, Ingrisch M, Unterrainer M, Dekorsy FJ, Lindner S, Ruf V, Brosch-Lenz J, Delker A, Böning G, Suchorska B, Niyazi M, Wetzel CH, Riemenschneider MJ, ... ... Brendel M, et al. Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas. Cancers. 14. PMID 35008218 DOI: 10.3390/cancers14010053 |
0.714 |
|
2021 |
Guedj E, Varrone A, Boellaard R, Albert NL, Barthel H, van Berckel B, Brendel M, Cecchin D, Ekmekcioglu O, Garibotto V, Lammertsma AA, Law I, Peñuelas I, Semah F, Traub-Weidinger T, et al. EANM procedure guidelines for brain PET imaging using [F]FDG, version 3. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34882261 DOI: 10.1007/s00259-021-05603-w |
0.671 |
|
2021 |
Kirchner MA, Holzgreve A, Brendel M, Orth M, Ruf VC, Steiger K, Pötter D, Gold L, Unterrainer M, Mittlmeier LM, Barci E, Kälin RE, Glass R, Lindner S, Kaiser L, et al. PSMA PET Imaging in Glioblastoma: A Preclinical Evaluation and Theranostic Outlook. Frontiers in Oncology. 11: 774017. PMID 34869017 DOI: 10.3389/fonc.2021.774017 |
0.674 |
|
2021 |
Mittlmeier LM, Todica A, Gildehaus FJ, Unterrainer M, Beyer L, Brendel M, Albert NL, Ledderose ST, Vettermann FJ, Schott M, Rodler S, Marcon J, Ilhan H, Cyran CC, Stief CG, et al. Ga-EMP-100 PET/CT-a novel ligand for visualizing c-MET expression in metastatic renal cell carcinoma-first in-human biodistribution and imaging results. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34708249 DOI: 10.1007/s00259-021-05596-6 |
0.616 |
|
2021 |
Xiang X, Wind K, Wiedemann T, Blume T, Shi Y, Briel N, Beyer L, Biechele G, Eckenweber F, Zatcepin A, Lammich S, Ribicic S, Tahirovic S, Willem M, Deussing M, ... ... Brendel M, et al. Microglial activation states drive glucose uptake and FDG-PET alterations in neurodegenerative diseases. Science Translational Medicine. 13: eabe5640. PMID 34644146 DOI: 10.1126/scitranslmed.abe5640 |
0.713 |
|
2021 |
Biechele G, Blume T, Deussing M, Zott B, Shi Y, Xiang X, Franzmeier N, Kleinberger G, Peters F, Ochs K, Focke C, Sacher C, Wind K, Schmidt C, Lindner S, ... ... Brendel M, et al. Pre-therapeutic microglia activation and sex determine therapy effects of chronic immunomodulation. Theranostics. 11: 8964-8976. PMID 34522221 DOI: 10.7150/thno.64022 |
0.694 |
|
2021 |
Etminani K, Soliman A, Davidsson A, Chang JR, Martínez-Sanchis B, Byttner S, Camacho V, Bauckneht M, Stegeran R, Ressner M, Agudelo-Cifuentes M, Chincarini A, Brendel M, Rominger A, Bruffaerts R, et al. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34328531 DOI: 10.1007/s00259-021-05483-0 |
0.379 |
|
2021 |
Willroider M, Roeber S, Horn AKE, Arzberger T, Scheifele M, Respondek G, Sabri O, Barthel H, Patt M, Mishchenko O, Schildan A, Mueller A, Koglin N, Stephens A, Levin J, ... ... Brendel M, et al. Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for Assessment of Progressive Supranuclear Palsy Tau Pathology With [ F]PI-2620. Frontiers in Neurology. 12: 684523. PMID 34276540 DOI: 10.3389/fneur.2021.684523 |
0.639 |
|
2021 |
Garibotto V, Albert NL, Barthel H, van Berckel B, Boellaard R, Brendel M, Cecchin D, Ekmekcioglu O, van de Giessen E, Guedj E, Lammerstma AA, Semah F, Traub-Weidinger T, Van Weehaeghe D, Morbelli S, et al. The approval of a disease-modifying treatment for Alzheimer's disease: impact and consequences for the nuclear medicine community. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34272989 DOI: 10.1007/s00259-021-05485-y |
0.488 |
|
2021 |
Mittlmeier LM, Suchorska B, Ruf V, Holzgreve A, Brendel M, Herms J, Bartenstein P, Tonn JC, Unterrainer M, Albert NL. F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors. Cancers. 13. PMID 34202726 DOI: 10.3390/cancers13133163 |
0.742 |
|
2021 |
Neitzel J, Franzmeier N, Rubinski A, Dichgans M, Brendel M, Malik R, Ewers M. KL-VS heterozygosity is associated with lower amyloid-dependent tau accumulation and memory impairment in Alzheimer's disease. Nature Communications. 12: 3825. PMID 34158479 DOI: 10.1038/s41467-021-23755-z |
0.352 |
|
2021 |
Mittlmeier LM, Brendel M, Beyer L, Albert NL, Todica A, Zacherl MJ, Wenter V, Herlemann A, Kretschmer A, Ledderose ST, Schmidt-Hegemann NS, Kunz WG, Ricke J, Bartenstein P, Ilhan H, et al. Feasibility of Different Tumor Delineation Approaches for F-PSMA-1007 PET/CT Imaging in Prostate Cancer Patients. Frontiers in Oncology. 11: 663631. PMID 34094956 DOI: 10.3389/fonc.2021.663631 |
0.709 |
|
2021 |
Vettermann FJ, Harris S, Schmitt J, Unterrainer M, Lindner S, Rauchmann BS, Palleis C, Weidinger E, Beyer L, Eckenweber F, Schuster S, Biechele G, Ferschmann C, Milenkovic VM, Wetzel CH, ... ... Brendel M, et al. Impact of TSPO Receptor Polymorphism on [F]GE-180 Binding in Healthy Brain and Pseudo-Reference Regions of Neurooncological and Neurodegenerative Disorders. Life (Basel, Switzerland). 11. PMID 34073557 DOI: 10.3390/life11060484 |
0.724 |
|
2021 |
Schmitt J, Palleis C, Sauerbeck J, Unterrainer M, Harris S, Prix C, Weidinger E, Katzdobler S, Wagemann O, Danek A, Beyer L, Rauchmann BS, Rominger A, Simons M, Bartenstein P, ... ... Brendel M, et al. Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome. Frontiers in Aging Neuroscience. 13: 661284. PMID 34054506 DOI: 10.3389/fnagi.2021.661284 |
0.696 |
|
2021 |
Song M, Beyer L, Kaiser L, Barthel H, van Eimeren T, Marek K, Nitschmann A, Scheifele M, Palleis C, Respondek G, Kern M, Biechele G, Hammes J, Bischof G, Barbe M, ... ... Brendel M, et al. Binding characteristics of [F]PI-2620 distinguish the clinically predicted tau isoform in different tauopathies by PET. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X211018904. PMID 34044665 DOI: 10.1177/0271678X211018904 |
0.584 |
|
2021 |
Song M, Scheifele M, Barthel H, van Eimeren T, Beyer L, Marek K, Eckenweber F, Palleis C, Kaiser L, Finze A, Kern M, Nitschmann A, Biechele G, Katzdobler S, Bischof G, ... ... Brendel M, et al. Feasibility of short imaging protocols for [F]PI-2620 tau-PET in progressive supranuclear palsy. European Journal of Nuclear Medicine and Molecular Imaging. PMID 34021393 DOI: 10.1007/s00259-021-05391-3 |
0.604 |
|
2021 |
Biechele G, Sebastian Monasor L, Wind K, Blume T, Parhizkar S, Arzberger T, Sacher C, Beyer L, Eckenweber F, Gildehaus FJ, von Ungern-Sternberg B, Willem M, Bartenstein P, Cumming P, Rominger A, ... ... Brendel M, et al. Glitter in the Darkness? Non-fibrillar β-amyloid Plaque Components Significantly Impact the β-amyloid PET Signal in Mouse Models of Alzheimer's Disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 34016733 DOI: 10.2967/jnumed.120.261858 |
0.747 |
|
2021 |
Unterrainer M, Ruf V, von Rohr K, Suchorska B, Mittlmeier LM, Beyer L, Brendel M, Wenter V, Kunz WG, Bartenstein P, Herms J, Niyazi M, Tonn JC, Albert NL. TERT-Promoter Mutational Status in Glioblastoma - Is There an Association With Amino Acid Uptake on Dynamic F-FET PET? Frontiers in Oncology. 11: 645316. PMID 33996563 DOI: 10.3389/fonc.2021.645316 |
0.749 |
|
2021 |
Palleis C, Brendel M, Finze A, Weidinger E, Bötzel K, Danek A, Beyer L, Nitschmann A, Kern M, Biechele G, Rauchmann BS, Häckert J, Höllerhage M, Stephens AW, Drzezga A, et al. Cortical [ F]PI-2620 Binding Differentiates Corticobasal Syndrome Subtypes. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33951244 DOI: 10.1002/mds.28624 |
0.546 |
|
2021 |
Beyer L, Gosewisch A, Lindner S, Völter F, Mittlmeier LM, Tiling R, Brendel M, Cyran CC, Unterrainer M, Rübenthaler J, Auernhammer CJ, Spitzweg C, Böning G, Gildehaus FJ, Jurkschat K, et al. Dosimetry and optimal scan time of [F]SiTATE-PET/CT in patients with neuroendocrine tumours. European Journal of Nuclear Medicine and Molecular Imaging. PMID 33928401 DOI: 10.1007/s00259-021-05351-x |
0.556 |
|
2021 |
Grosch M, Beyer L, Lindner M, Kaiser L, Ahmadi SA, Stockbauer A, Bartenstein P, Dieterich M, Brendel M, Zwergal A, Ziegler S. Metabolic connectivity-based single subject classification by multi-regional linear approximation in the rat. Neuroimage. 235: 118007. PMID 33831550 DOI: 10.1016/j.neuroimage.2021.118007 |
0.476 |
|
2021 |
Mittlmeier LM, Ledderose ST, Schott M, Brendel M, Beyer L, Theurich S, Mayr D, Walz C, Kunz WG, Ricke J, Bartenstein P, Ilhan H, Staehler M, Unterrainer M. Immature Plasma Cell Myeloma Mimics Metastatic Renal Cell Carcinoma on F-PSMA-1007 PET/CT Due to Endothelial PSMA-Expression. Diagnostics (Basel, Switzerland). 11. PMID 33802288 DOI: 10.3390/diagnostics11030423 |
0.501 |
|
2021 |
Nuebling GS, Prix C, Brendel M, Beyer L, Wlasich E, Loosli SV, Barthel H, Sabri O, Bartenstein P, Vöglein J, Danek A, Rominger A, Edbauer D, Haass C, Levin J. Low-degree trisomy 21 mosaicism promotes early-onset Alzheimer disease. Neurobiology of Aging. PMID 33789815 DOI: 10.1016/j.neurobiolaging.2021.02.021 |
0.642 |
|
2021 |
Kreuzer A, Sauerbeck J, Scheifele M, Stockbauer A, Schönecker S, Prix C, Wlasich E, Loosli SV, M Kazmierczak P, Unterrainer M, Catak C, Janowitz D, Pogarell O, Palleis C, Perneczky R, ... ... Brendel M, et al. Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer's Disease. Frontiers in Aging Neuroscience. 13: 611595. PMID 33603657 DOI: 10.3389/fnagi.2021.611595 |
0.669 |
|
2021 |
Schöberl F, Pradhan C, Grosch M, Brendel M, Jostes F, Obermaier K, Sowa C, Jahn K, Bartenstein P, Brandt T, Dieterich M, Zwergal A. Bilateral vestibulopathy causes selective deficits in recombining novel routes in real space. Scientific Reports. 11: 2695. PMID 33514827 DOI: 10.1038/s41598-021-82427-6 |
0.421 |
|
2021 |
Biechele G, Rauchmann B, Janowitz D, Buerger K, Franzmeier N, Weidinger E, Guersel S, Schuster S, Finze A, Harris S, Schmitt J, Beyer L, Lindner S, Unterrainer M, Eckenweber F, ... ... Brendel M, et al. Associations between sex, body mass index, and the individual microglial response in Alzheimer’s disease Alzheimer's & Dementia. 17. DOI: 10.1002/alz.052772 |
0.553 |
|
2021 |
Biechele G, Monasor LS, Wind K, Blume T, Parhizkar S, Arzberger T, Sacher C, Beyer L, Eckenweber F, Gildehaus FJ, von Ungern‐Sternberg B, Willem M, Bartenstein P, Cumming P, Rominger A, ... ... Brendel M, et al. Glitter in the darkness? Non‐fibrillar β‐amyloid plaque components significantly impact the β‐amyloid PET signal Alzheimer's & Dementia. 17. DOI: 10.1002/alz.051983 |
0.492 |
|
2020 |
Biechele G, Wind K, Blume T, Sacher C, Beyer L, Eckenweber F, Franzmeier N, Ewers M, Zott B, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Tahirovic S, Willem M, Bartenstein P, ... ... Brendel M, et al. Microglial Activation in the Right Amygdala-Entorhinal-Hippocampal Complex is Associated with Preserved Spatial Learning in App mice. Neuroimage. 117707. PMID 33385560 DOI: 10.1016/j.neuroimage.2020.117707 |
0.631 |
|
2020 |
Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Sauerbeck J, Scheifele M, Prix C, Unterrainer M, Catak C, Pogarell O, Palleis C, Perneczky R, Danek A, Buerger K, Bartenstein P, ... ... Brendel M, et al. Cognitive reserve hypothesis in frontotemporal dementia: A FDG-PET study. Neuroimage. Clinical. 29: 102535. PMID 33369564 DOI: 10.1016/j.nicl.2020.102535 |
0.509 |
|
2020 |
Beyer L, Brendel M. Imaging of Tau Pathology in Neurodegenerative Diseases: An Update. Seminars in Nuclear Medicine. PMID 33353724 DOI: 10.1053/j.semnuclmed.2020.12.004 |
0.413 |
|
2020 |
Biechele G, Franzmeier N, Blume T, Ewers M, Luque JM, Eckenweber F, Sacher C, Beyer L, Ruch-Rubinstein F, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Cumming P, Bartenstein P, Rominger A, ... ... Brendel M, et al. Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases. Journal of Neuroinflammation. 17: 374. PMID 33317543 DOI: 10.1186/s12974-020-02046-2 |
0.66 |
|
2020 |
Palleis C, Sauerbeck J, Beyer L, Harris S, Schmitt J, Morenas-Rodriguez E, Finze A, Nitschmann A, Ruch-Rubinstein F, Eckenweber F, Biechele G, Blume T, Shi Y, Weidinger E, Prix C, ... ... Brendel M, et al. In Vivo Assessment of Neuroinflammation in 4-Repeat Tauopathies. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33245166 DOI: 10.1002/mds.28395 |
0.701 |
|
2020 |
Brendel M, Barthel H, van Eimeren T, Marek K, Beyer L, Song M, Palleis C, Gehmeyr M, Fietzek U, Respondek G, Sauerbeck J, Nitschmann A, Zach C, Hammes J, Barbe MT, et al. Assessment of 18F-PI-2620 as a Biomarker in Progressive Supranuclear Palsy. Jama Neurology. 77: 1408-1419. PMID 33165511 DOI: 10.1001/Jamaneurol.2020.2526 |
0.601 |
|
2020 |
Buchecker V, Waldron AM, van Dijk RM, Koska I, Brendel M, von Ungern-Sternberg B, Lindner S, Gildehaus FJ, Ziegler S, Bartenstein P, Potschka H. [F]MPPF and [F]FDG μPET imaging in rats: impact of transport and restraint stress. Ejnmmi Research. 10: 112. PMID 32990819 DOI: 10.1186/s13550-020-00693-3 |
0.439 |
|
2020 |
Henkel R, Brendel M, Paolini M, Brendel E, Beyer L, Gutzeit A, Pogarell O, Rominger A, Blautzik J. FDG PET Data is Associated with Cognitive Performance in Patients from a Memory Clinic. Journal of Alzheimer's Disease : Jad. 78: 207-216. PMID 32955465 DOI: 10.3233/JAD-200826 |
0.331 |
|
2020 |
Werner G, Damme M, Schludi M, Gnörich J, Wind K, Fellerer K, Wefers B, Wurst W, Edbauer D, Brendel M, Haass C, Capell A. Loss of TMEM106B potentiates lysosomal and FTLD-like pathology in progranulin-deficient mice. Embo Reports. e50241. PMID 32929860 DOI: 10.15252/Embr.202050241 |
0.413 |
|
2020 |
Völk S, Unterrainer M, Albert NL, Havla J, Gerdes LA, Schumacher M, Brendel M, Kaiser L, Adorjan K, Rupprecht R, Bartenstein P, Kümpfel T, Danek A. TSPO PET With 18F-GE-180 to Differentiate Variants of Multiple Sclerosis: Relapsing-Remitting Multiple Sclerosis, Tumefactive Demyelination, and Baló's Concentric Sclerosis. Clinical Nuclear Medicine. 45: e447-e448. PMID 32796248 DOI: 10.1097/RLU.0000000000003220 |
0.654 |
|
2020 |
Ewers M, Biechele G, Suárez-Calvet M, Sacher C, Blume T, Morenas-Rodriguez E, Deming Y, Piccio L, Cruchaga C, Kleinberger G, Shaw L, Trojanowski JQ, Herms J, Dichgans M, ... Brendel M, et al. Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation. Embo Molecular Medicine. e12308. PMID 32790063 DOI: 10.15252/Emmm.202012308 |
0.712 |
|
2020 |
Brendel M, Catak C, Beyer L, Linn J, Wahl H, Janowitz D, Rominger A, Patt M, Barthel H, Sabri O, Bartenstein P, Wollenweber FA. Colocalization of Tau but Not β-Amyloid with Cortical Superficial Siderosis in a Case with Probable CAA. Case Reports in Neurology. 12: 232-237. PMID 32774280 DOI: 10.1159/000506765 |
0.496 |
|
2020 |
Lu J, Bao W, Li M, Li L, Zhang Z, Alberts I, Brendel M, Cumming P, Lu H, Xiao Z, Zuo C, Guan Y, Zhao Q, Rominger A. Associations of [F]-APN-1607 Tau PET Binding in the Brain of Alzheimer's Disease Patients With Cognition and Glucose Metabolism. Frontiers in Neuroscience. 14: 604. PMID 32694971 DOI: 10.3389/Fnins.2020.00604 |
0.478 |
|
2020 |
Zacherl MJ, Todica A, Wängler C, Schirrmacher R, Hajebrahimi MA, Pircher J, Li X, Lindner S, Brendel M, Bartenstein P, Massberg S, Brunner S, Lehner S, Hacker M, Huber BC. Molecular imaging of cardiac CXCR4 expression in a mouse model of acute myocardial infarction using a novel Ga-mCXCL12 PET tracer. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. PMID 32676914 DOI: 10.1007/s12350-020-02262-6 |
0.422 |
|
2020 |
Eckenweber F, Medina-Luque J, Blume T, Sacher C, Biechele G, Wind K, Deussing M, Briel N, Lindner S, Boening G, von Ungern-Sternberg B, Unterrainer M, Albert NL, Zwergal A, Levin J, ... ... Brendel M, et al. Longitudinal TSPO expression in tau transgenic P301S mice predicts increased tau accumulation and deteriorated spatial learning. Journal of Neuroinflammation. 17: 208. PMID 32660586 DOI: 10.1186/S12974-020-01883-5 |
0.712 |
|
2020 |
Albert NL, Unterrainer M, Kaiser L, Brendel M, Vettermann FJ, Holzgreve A, Bartenstein P. In response to: Anatomy of F-GE180, a failed radioligand for the TSPO protein. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32524162 DOI: 10.1007/s00259-020-04885-w |
0.641 |
|
2020 |
Sacher C, Blume T, Beyer L, Biechele G, Sauerbeck J, Eckenweber F, Deussing M, Focke C, Parhizkar S, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Baumann K, Tahirovic S, Kleinberger G, ... ... Brendel M, et al. Asymmetry of fibrillar plaque burden in amyloid mouse models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 32414948 DOI: 10.2967/Jnumed.120.242750 |
0.743 |
|
2020 |
Becker-Bense S, Willoch F, Stephan T, Brendel M, Yakushev I, Habs M, Ziegler S, Herz M, Schwaiger M, Dieterich M, Bartenstein P. Direct comparison of activation maps during galvanic vestibular stimulation: A hybrid H2[15 O] PET-BOLD MRI activation study. Plos One. 15: e0233262. PMID 32413079 DOI: 10.1371/journal.pone.0233262 |
0.529 |
|
2020 |
Beyer L, Nitschmann A, Barthel H, van Eimeren T, Unterrainer M, Sauerbeck J, Marek K, Song M, Palleis C, Respondek G, Hammes J, Barbe MT, Onur Ö, Jessen F, Saur D, ... ... Brendel M, et al. Early-phase [F]PI-2620 tau-PET imaging as a surrogate marker of neuronal injury. European Journal of Nuclear Medicine and Molecular Imaging. PMID 32318783 DOI: 10.1007/S00259-020-04788-W |
0.708 |
|
2020 |
Beyer L, Brendel M, Scheiwein F, Sauerbeck J, Hosakawa C, Alberts I, Shi K, Bartenstein P, Ishii K, Seibyl J, Cumming P, Rominger A. Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography. Journal of Alzheimer's Disease : Jad. PMID 31985461 DOI: 10.3233/Jad-190818 |
0.536 |
|
2020 |
Schöberl F, Pradhan C, Irving S, Buerger K, Xiong G, Kugler G, Kohlbecher S, Engmann J, Werner P, Brendel M, Schneider E, Perneczky R, Jahn K, la Fougère C, Bartenstein P, et al. Real-space navigation testing differentiates between amyloid-positive and -negative aMCI. Neurology. PMID 31896617 DOI: 10.1212/Wnl.0000000000008758 |
0.362 |
|
2020 |
Biechele G, Franzmeier N, Ewers M, Blume T, Eckenweber F, Sacher C, Luque JM, Beyer L, Ruch‐Rubinstein F, Lindner S, Gildehaus FJ, von Ungern‐Sternberg B, Bartenstein P, Rominger A, Höglinger G, ... ... Brendel M, et al. Microglial activation in vivo is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of Alzheimer’s disease Alzheimer's & Dementia. 16. DOI: 10.1002/alz.039574 |
0.402 |
|
2020 |
Biechele G, Sacher C, Blume T, Beyer L, Sauerbeck J, Eckenweber F, Deussing M, Focke C, Parhizkar S, Lindner S, Gildehaus FJ, von Ungern‐Sternberg B, Baumann K, Tahirovic S, Kleinberger G, ... ... Brendel M, et al. Asymmetry of plaque burden in amyloid mouse models Alzheimer's & Dementia. 16. DOI: 10.1002/alz.039153 |
0.394 |
|
2019 |
Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Van Laere K, Kramberger MG, Trost M, Grmek M, Garibotto V, ... ... Brendel M, et al. Metabolic correlates of dopaminergic loss in dementia with lewy bodies. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31840326 DOI: 10.1002/Mds.27945 |
0.494 |
|
2019 |
Vöglein J, Willem M, Trambauer J, Schönecker S, Dieterich M, Biskup S, Giudici C, Utz K, Oberstein T, Brendel M, Rominger A, Danek A, Steiner H, Haass C, Levin J. Identification of a rare presenilin 1 single amino acid deletion mutation (F175del) with unusual amyloid-β processing effects. Neurobiology of Aging. PMID 31627977 DOI: 10.1016/J.Neurobiolaging.2019.08.034 |
0.462 |
|
2019 |
Unterrainer M, Ruf V, Cyran CC, Brendel M, Thon N, Herms J, Schüller U, Tonn JC, Bartenstein P, Albert NL. Identification of Distant Metastases From Recurrent Gliosarcoma Using Whole-Body 18F-FDG PET/CT. Clinical Nuclear Medicine. 44: 923-924. PMID 31584491 DOI: 10.1097/Rlu.0000000000002790 |
0.763 |
|
2019 |
Schönecker S, Brendel M, Palleis C, Beyer L, Höglinger GU, Schuh E, Rauchmann BS, Sauerbeck J, Rohrer G, Sonnenfeld S, Furukawa K, Ishiki A, Okamura N, Bartenstein P, Dieterich M, et al. PET Imaging of Astrogliosis and Tau Facilitates Diagnosis of Parkinsonian Syndromes. Frontiers in Aging Neuroscience. 11: 249. PMID 31572166 DOI: 10.3389/fnagi.2019.00249 |
0.533 |
|
2019 |
Unterrainer M, Fleischmann DF, Vettermann F, Ruf V, Kaiser L, Nelwan D, Lindner S, Brendel M, Wenter V, Stöcklein S, Herms J, Milenkovic VM, Rupprecht R, Tonn JC, Belka C, et al. TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative F-GE-180 PET study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31486876 DOI: 10.1007/S00259-019-04491-5 |
0.767 |
|
2019 |
Beyer L, Schnabel J, Kazmierczak P, Ewers M, Schönecker S, Prix C, Meyer-Wilmes J, Unterrainer M, Catak C, Pogarell O, Perneczky R, Albert NL, Bartenstein P, Danek A, Buerger K, ... ... Brendel M, et al. Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease. Neuroimage. Clinical. 24: 101949. PMID 31398553 DOI: 10.1016/j.nicl.2019.101949 |
0.646 |
|
2019 |
Brendel M, Deussing M, Blume T, Kaiser L, Probst F, Overhoff F, Peters F, von Ungern-Sternberg B, Ryazanov S, Leonov A, Griesinger C, Zwergal A, Levin J, Bartenstein P, Yakushev I, et al. Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer's disease tau. Alzheimer's Research & Therapy. 11: 67. PMID 31370885 DOI: 10.1186/S13195-019-0522-Z |
0.681 |
|
2019 |
Sacher C, Blume T, Beyer L, Peters F, Eckenweber F, Sgobio C, Deussing M, Albert NL, Unterrainer M, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Brzak I, Neumann U, Saito T, ... ... Brendel M, et al. Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second Generation Amyloid-beta Mouse Model. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 31302633 DOI: 10.2967/Jnumed.119.227322 |
0.752 |
|
2019 |
Götzl JK, Brendel M, Werner G, Parhizkar S, Sebastian Monasor L, Kleinberger G, Colombo AV, Deussing M, Wagner M, Winkelmann J, Diehl-Schmid J, Levin J, Fellerer K, Reifschneider A, Bultmann S, et al. Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism. Embo Molecular Medicine. PMID 31122931 DOI: 10.15252/Emmm.201809711 |
0.563 |
|
2019 |
Albert NL, Unterrainer M, Brendel M, Kaiser L, Zweckstetter M, Cumming P, Bartenstein P. In response to: The validity of F-GE180 as a TSPO imaging agent. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30826897 DOI: 10.1007/S00259-019-04294-8 |
0.636 |
|
2019 |
Nack A, Brendel M, Nedelcu J, Daerr M, Nyamoya S, Beyer C, Focke C, Deussing M, Hoornaert C, Ponsaerts P, Schmitz C, Bartenstein P, Rominger A, Kipp M. Expression of Translocator Protein and [18F]-GE180 Ligand Uptake in Multiple Sclerosis Animal Models. Cells. 8. PMID 30696113 DOI: 10.3390/cells8020094 |
0.509 |
|
2019 |
Parhizkar S, Arzberger T, Brendel M, Kleinberger G, Deussing M, Focke C, Nuscher B, Xiong M, Ghasemigharagoz A, Katzmarski N, Krasemann S, Lichtenthaler SF, Müller SA, Colombo A, Monasor LS, et al. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE. Nature Neuroscience. PMID 30617257 DOI: 10.1038/S41593-018-0296-9 |
0.664 |
|
2019 |
Brendel M, Barthel H, van Eimeren T, Marek K, Beyer L, Song M, Palleis C, Respondek G, Sauerbeck J, Hammes J, Barbe M, Onur OA, Jessen F, Saur D, Schroeter ML, et al. IC-P-161: 18F-PI2620 TAU-PET IN PROGRESSIVE SUPRANUCLEAR PALSY: A MULTI-CENTER EVALUATION Alzheimer's & Dementia. 15: P128-P129. DOI: 10.1016/j.jalz.2019.06.4276 |
0.528 |
|
2019 |
Brendel M, Barthel H, Eimeren Tv, Marek K, Beyer L, Song M, Palleis C, Respondek G, Sauerbeck J, Hammes J, Barbe M, Onur OA, Jessen F, Saur D, Schroeter ML, et al. Ic-P-161: 18F-Pi2620 Tau-Pet In Progressive Supranuclear Palsy: A Multi-Center Evaluation Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.2783 |
0.659 |
|
2018 |
Feil K, Brendel M, Hensler M, Bartenstein P, Seelos K, Dieterich M, Rominger A, Danek A. FDG-PET in a Case of Very Late-onset Huntington's Disease. Movement Disorders Clinical Practice. 5: 227-228. PMID 30746408 DOI: 10.1002/mdc3.12601 |
0.538 |
|
2018 |
Brendel M, Jaworska A, Overhoff F, Blume T, Probst F, Gildehaus FJ, Bartenstein P, Haass C, Bohrmann B, Herms J, Willem M, Rominger A. Efficacy of chronic BACE1 inhibition in PS2APP mice depends on the regional Aβ deposition rate and plaque burden at treatment initiation. Theranostics. 8: 4957-4968. PMID 30429879 DOI: 10.7150/Thno.27868 |
0.727 |
|
2018 |
Blume T, Focke C, Peters F, Deussing M, Albert NL, Lindner S, Gildehaus FJ, von Ungern-Sternberg B, Ozmen L, Baumann K, Bartenstein P, Rominger A, Herms J, Brendel M. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study. Journal of Neuroinflammation. 15: 307. PMID 30400912 DOI: 10.1186/S12974-018-1347-6 |
0.723 |
|
2018 |
van Dijk RM, Di Liberto V, Brendel M, Waldron AM, Möller C, Gildehaus FJ, von Ungern-Sternberg B, Lindner M, Ziegler S, Hellweg R, Gass P, Bartenstein P, Potschka H. Imaging biomarkers of behavioral impairments: A pilot micro-positron emission tomographic study in a rat electrical post-status epilepticus model. Epilepsia. PMID 30370531 DOI: 10.1111/epi.14586 |
0.46 |
|
2018 |
Focke C, Blume T, Zott B, Yuan Shi Y, Deussing M, Peters F, Schmidt C, Kleinberger G, Lindner S, Gildehaus FJ, Beyer L, von Ungern-Sternberg B, Bartenstein P, Ozmen L, Baumann K, ... ... Brendel M, et al. Early and longitudinal microglial activation but not amyloid accumulation predict cognitive outcome in PS2APP mice. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 30262517 DOI: 10.2967/Jnumed.118.217703 |
0.692 |
|
2018 |
Unterrainer M, Fleischmann DF, Diekmann C, Vomacka L, Lindner S, Vettermann F, Brendel M, Wenter V, Ertl-Wagner B, Herms J, Wetzel C, Rupprecht R, Tonn JC, Belka C, Bartenstein P, et al. Comparison of F-GE-180 and dynamic F-FET PET in high grade glioma: a double-tracer pilot study. European Journal of Nuclear Medicine and Molecular Imaging. PMID 30244386 DOI: 10.1007/S00259-018-4166-1 |
0.775 |
|
2018 |
Irving S, Schöberl F, Pradhan C, Brendel M, Bartenstein P, Dieterich M, Brandt T, Zwergal A. A novel real-space navigation paradigm reveals age- and gender-dependent changes of navigational strategies and hippocampal activation. Journal of Neurology. PMID 30073501 DOI: 10.1007/s00415-018-8987-4 |
0.305 |
|
2018 |
Brendel M, Sauerbeck J, Greven S, Kotz S, Scheiwein F, Blautzik J, Delker A, Pogarell O, Ishii K, Bartenstein P, Rominger A. Serotonin Selective Reuptake Inhibitor Treatment Improves Cognition and Grey Matter Atrophy but not Amyloid Burden During Two-Year Follow-Up in Mild Cognitive Impairment and Alzheimer's Disease Patients with Depressive Symptoms. Journal of Alzheimer's Disease : Jad. 65: 793-806. PMID 30010116 DOI: 10.3233/JAD-170387 |
0.416 |
|
2018 |
Beyer L, Meyer-Wilmes J, Schönecker S, Schnabel J, Brendel E, Prix C, Nübling G, Unterrainer M, Albert NL, Pogarell O, Perneczky R, Catak C, Bürger K, Bartenstein P, Bötzel K, ... ... Brendel M, et al. Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging? Frontiers in Neurology. 9: 483. PMID 29973914 DOI: 10.3389/fneur.2018.00483 |
0.717 |
|
2018 |
Schöberl F, Levin J, Remi J, Goldschagg N, Eren O, Okamura N, Unterrainer M, Rominger A, Albert N, Brendel M. IgLON5: A case with predominant cerebellar tau deposits and leptomeningeal inflammation. Neurology. PMID 29970401 DOI: 10.1212/WNL.0000000000005859 |
0.475 |
|
2018 |
Di Liberto V, Maarten van Dijk R, Brendel M, Waldron AM, Möller C, Koska I, Seiffert I, Gualtieri F, Gildehaus FJ, von Ungern-Sternberg B, Lindner M, Ziegler S, Palme R, Hellweg R, Gass P, et al. Imaging correlates of behavioral impairments: An experimental PET study in the rat pilocarpine epilepsy model. Neurobiology of Disease. PMID 29933054 DOI: 10.1016/J.Nbd.2018.06.010 |
0.546 |
|
2018 |
Brendel M, Yousefi BH, Blume T, Herz M, Focke C, Deussing M, Peters F, Lindner S, von Ungern-Sternberg B, Drzezga A, Bartenstein P, Haass C, Okamura N, Herms J, Yakushev I, et al. Comparison of F-T807 and F-THK5117 PET in a Mouse Model of Tau Pathology. Frontiers in Aging Neuroscience. 10: 174. PMID 29930508 DOI: 10.3389/Fnagi.2018.00174 |
0.765 |
|
2018 |
Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, Unterrainer M, Albert NL, Lindner S, von Ungern-Sternberg B, Baumann K, Zwergal A, Bartenstein P, Herms J, Rominger A, ... Brendel M, et al. Data on specificity of [F]GE180 uptake for TSPO expression in rodent brain and myocardium. Data in Brief. 19: 331-336. PMID 29892655 DOI: 10.1016/J.Dib.2018.04.133 |
0.738 |
|
2018 |
Unterrainer M, Fleischmann DF, Lindner S, Brendel M, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M, Albert NL. Detection of Cerebrospinal Fluid Dissemination of Recurrent Glioblastoma Using TSPO-PET With 18F-GE-180. Clinical Nuclear Medicine. 43: 518-519. PMID 29742608 DOI: 10.1097/RLU.0000000000002113 |
0.709 |
|
2018 |
Sauerbeck J, Ishii K, Hosokawa C, Kaida H, Scheiwein FT, Hanaoka K, Rominger A, Brendel M, Bartenstein P, Murakami T. The correlation between striatal and cortical binding ratio of C-PiB-PET in amyloid-uptake-positive patients. Annals of Nuclear Medicine. 32: 398-403. PMID 29730823 DOI: 10.1007/s12149-018-1258-8 |
0.516 |
|
2018 |
Unterrainer M, Mahler C, Vomacka L, Lindner S, Havla J, Brendel M, Böning G, Ertl-Wagner B, Kümpfel T, Milenkovic VM, Rupprecht R, Kerschensteiner M, Bartenstein P, Albert NL. TSPO PET with [F]GE-180 sensitively detects focal neuroinflammation in patients with relapsing-remitting multiple sclerosis. European Journal of Nuclear Medicine and Molecular Imaging. 45: 1423-1431. PMID 29523925 DOI: 10.1007/S00259-018-3974-7 |
0.688 |
|
2017 |
Brendel M, Wagner L, Levin J, Zach C, Lindner S, Bartenstein P, Okamura N, Rominger A. Perfusion-Phase [F]THK5351 Tau-PET Imaging as a Surrogate Marker for Neurodegeneration. Journal of Alzheimer's Disease Reports. 1: 109-113. PMID 30480233 DOI: 10.3233/ADR-170023 |
0.604 |
|
2017 |
Brendel M, Schönecker S, Höglinger G, Lindner S, Havla J, Blautzik J, Sauerbeck J, Rohrer G, Zach C, Vettermann F, Lang AE, Golbe L, Nübling G, Bartenstein P, Furukawa K, et al. [18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy. Frontiers in Aging Neuroscience. 9: 440. PMID 29387005 DOI: 10.3389/fnagi.2017.00440 |
0.569 |
|
2017 |
Zwergal A, Günther L, Brendel M, Beck R, Lindner S, Xiong G, Eilles E, Unterrainer M, Albert NL, Becker-Bense S, Brandt T, Ziegler S, la Fougère C, Dieterich M, Bartenstein P. In Vivo Imaging of Glial Activation after Unilateral Labyrinthectomy in the Rat: A [18F]GE180-PET Study. Frontiers in Neurology. 8: 665. PMID 29312111 DOI: 10.3389/fneur.2017.00665 |
0.679 |
|
2017 |
Vomacka L, Albert NL, Lindner S, Unterrainer M, Mahler C, Brendel M, Ermoschkin L, Gosewisch A, Brunegraf A, Buckley C, Kümpfel T, Rupprecht R, Ziegler S, Kerschensteiner M, Bartenstein P, et al. TSPO imaging using the novel PET ligand [(18)F]GE-180: quantification approaches in patients with multiple sclerosis. Ejnmmi Research. 7: 89. PMID 29150726 DOI: 10.1186/S13550-017-0340-X |
0.713 |
|
2017 |
Deussing M, Blume T, Vomacka L, Mahler C, Focke C, Todica A, Unterrainer M, Albert NL, Lindner S, von Ungern-Sternberg B, Baumann K, Zwergal A, Bartenstein P, Herms J, Rominger A, ... Brendel M, et al. Coupling between physiological TSPO expression in brain and myocardium allows stabilization of late-phase cerebral [(18)F]GE180 PET quantification. Neuroimage. PMID 28988133 DOI: 10.1016/J.Neuroimage.2017.10.006 |
0.745 |
|
2017 |
Brendel M, Schnabel J, Schönecker S, Wagner L, Brendel E, Meyer-Wilmes J, Unterrainer M, Schildan A, Patt M, Prix C, Ackl N, Catak C, Pogarell O, Levin J, Danek A, et al. Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28932894 DOI: 10.1007/s00259-017-3832-z |
0.605 |
|
2017 |
Albert NL, Unterrainer M, Fleischmann DF, Lindner S, Vettermann F, Brunegraf A, Vomacka L, Brendel M, Wenter V, Wetzel C, Rupprecht R, Tonn JC, Belka C, Bartenstein P, Niyazi M. TSPO PET for glioma imaging using the novel ligand (18)F-GE-180: first results in patients with glioblastoma. European Journal of Nuclear Medicine and Molecular Imaging. PMID 28821920 DOI: 10.1007/s00259-017-3799-9 |
0.705 |
|
2017 |
Brendel M, Focke C, Blume T, Peters F, Deussing M, Probst F, Jaworska A, Overhoff F, Albert N, Lindner S, von Ungern-Sternberg B, Bartenstein P, Haass C, Kleinberger G, Herms J, et al. Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life-Span of Wild-Type Mice: A PET Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 28705919 DOI: 10.2967/Jnumed.117.195107 |
0.779 |
|
2017 |
Blautzik J, Kotz S, Brendel M, Sauerbeck J, Vettermann F, Winter Y, Bartenstein P, Ishii K, Rominger A. Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 28697560 DOI: 10.3233/JAD-170064 |
0.502 |
|
2017 |
Unterrainer M, Vettermann F, Brendel M, Holzgreve A, Lifschitz M, Zähringer M, Suchorska B, Wenter V, Illigens BM, Bartenstein P, Albert NL. Towards standardization of (18)F-FET PET imaging: do we need a consistent method of background activity assessment? Ejnmmi Research. 7: 48. PMID 28560582 DOI: 10.1186/s13550-017-0295-y |
0.713 |
|
2017 |
Kleinberger G, Brendel M, Mracsko E, Wefers B, Groeneweg L, Xiang X, Focke C, Deußing M, Suárez-Calvet M, Mazaheri F, Parhizkar S, Pettkus N, Wurst W, Feederle R, Bartenstein P, et al. The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism. The Embo Journal. PMID 28559417 DOI: 10.15252/Embj.201796516 |
0.575 |
|
2017 |
Russmann V, Brendel M, Mille E, Helm-Vicidomini A, Beck R, Günther L, Lindner S, Rominger A, Keck M, Salvamoser JD, Albert NL, Bartenstein P, Potschka H. Identification of brain regions predicting epileptogenesis by serial [(18)F]GE-180 positron emission tomography imaging of neuroinflammation in a rat model of temporal lobe epilepsy. Neuroimage. Clinical. 15: 35-44. PMID 28462087 DOI: 10.1016/j.nicl.2017.04.003 |
0.686 |
|
2017 |
Blautzik J, Brendel M, Sauerbeck J, Kotz S, Scheiwein F, Bartenstein P, Seibyl J, Rominger A. Reference region selection and the association between the rate of amyloid accumulation over time and the baseline amyloid burden. European Journal of Nuclear Medicine and Molecular Imaging. 44: 1364-1374. PMID 28326436 DOI: 10.1007/s00259-017-3666-8 |
0.543 |
|
2017 |
Brendel M, Kleinberger G, Probst F, Jaworska A, Overhoff F, Blume T, Albert NL, Carlsen J, Lindner S, Gildehaus FJ, Ozmen L, Suárez-Calvet M, Bartenstein P, Baumann K, Ewers M, et al. Increase of TREM2 during Aging of an Alzheimer's Disease Mouse Model Is Paralleled by Microglial Activation and Amyloidosis. Frontiers in Aging Neuroscience. 9: 8. PMID 28197095 DOI: 10.3389/Fnagi.2017.00008 |
0.772 |
|
2017 |
Daerr S, Brendel M, Zach C, Mille E, Schilling D, Zacherl MJ, Bürger K, Danek A, Pogarell O, Schildan A, Patt M, Barthel H, Sabri O, Bartenstein P, Rominger A. Evaluation of early-phase [(18)F]-florbetaben PET acquisition in clinical routine cases. Neuroimage. Clinical. 14: 77-86. PMID 28138429 DOI: 10.1016/j.nicl.2016.10.005 |
0.599 |
|
2017 |
Wenter V, Albert NL, Brendel M, Fendler WP, Cyran CC, Bartenstein P, Friederichs J, Müller JP, Militz M, Hacker M, Hungerer S. [(18)F]FDG PET accurately differentiates infected and non-infected non-unions after fracture fixation. European Journal of Nuclear Medicine and Molecular Imaging. 44: 432-440. PMID 27704194 DOI: 10.1007/s00259-016-3528-9 |
0.613 |
|
2017 |
Scheiwein FT, Ishii K, Hosokawa C, Kaida H, Hyodo T, Hanaoka K, Brendel M, Bartenstein P, Rominger A, Murakami T. Regional Differences in Amyloid Deposition between 11C-Pib PET Positive Patients with and without Elevated Striatal Amyloid Uptake Journal of Alzheimer’S Disease & Parkinsonism. 7. DOI: 10.4172/2161-0460.1000317 |
0.502 |
|
2017 |
Zwergal A, Günther L, Brendel M, Beck R, Lindner S, Xiong G, Eilles E, Unterrainer M, Albert N, Becker-Bense S, Ziegler S, la Fougere C, Bartenstein P, Brandt T, Dieterich M. P 61 Glial activation accelerates behavioural compensation of acute unilateral vestibulopathy Clinical Neurophysiology. 128: e358. DOI: 10.1016/j.clinph.2017.06.137 |
0.546 |
|
2016 |
Schönecker S, Prix C, Raiser T, Ackl N, Wlasich E, Stenglein-Krapf G, Mille E, Brendel M, Sabri O, Patt M, Barthel H, Bartenstein P, Levin J, Rominger A, Danek A. [Amyloid positron-emission-tomography with [(18) F]-florbetaben in the diagnostic workup of dementia patients]. Der Nervenarzt. PMID 27913818 DOI: 10.1007/s00115-016-0249-z |
0.578 |
|
2016 |
Romagna A, Unterrainer M, Schmid-Tannwald C, Brendel M, Tonn JC, Nachbichler SB, Muacevic A, Bartenstein P, Kreth FW, Albert NL. Suspected recurrence of brain metastases after focused high dose radiotherapy: can [(18)F]FET- PET overcome diagnostic uncertainties? Radiation Oncology (London, England). 11: 139. PMID 27769279 DOI: 10.1186/s13014-016-0713-8 |
0.683 |
|
2016 |
Mille E, Levin J, Brendel M, Zach C, Barthel H, Sabri O, Bötzel K, Bartenstein P, Danek A, Rominger A. Cerebral Glucose Metabolism and Dopaminergic Function in Patients with Corticobasal Syndrome. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 27572945 DOI: 10.1111/jon.12391 |
0.378 |
|
2016 |
Wollenweber FA, Därr S, Müller C, Duering M, Buerger K, Zietemann V, Malik R, Brendel M, Ertl-Wagner B, Bartenstein P, Rominger A, Dichgans M. Prevalence of Amyloid Positron Emission Tomographic Positivity in Poststroke Mild Cognitive Impairment. Stroke; a Journal of Cerebral Circulation. PMID 27539301 DOI: 10.1161/STROKEAHA.116.013778 |
0.454 |
|
2016 |
Holzgreve A, Brendel M, Gu S, Carlsen J, Mille E, Böning G, Mastrella G, Unterrainer M, Gildehaus FJ, Rominger A, Bartenstein P, Kälin RE, Glass R, Albert NL. Monitoring of Tumor Growth with [(18)F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches. Frontiers in Neuroscience. 10: 260. PMID 27378835 DOI: 10.3389/fnins.2016.00260 |
0.712 |
|
2016 |
Högenauer M, Brendel M, Delker A, Därr S, Weiss M, Bartenstein P, Rominger A, Alzheimer's Disease Neuroimaging Initiative. Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation. Current Alzheimer Research. 13: 597-607. PMID 27025775 DOI: 10.2174/156720501304160325175855 |
0.576 |
|
2016 |
Overhoff F, Brendel M, Jaworska A, Korzhova V, Delker A, Probst F, Focke C, Gildehaus FJ, Carlsen J, Baumann K, Haass C, Bartenstein P, Herms J, Rominger A. Automated Spatial Brain Normalization and Hindbrain White Matter Reference Tissue Give Improved [(18)F]-Florbetaben PET Quantitation in Alzheimer's Model Mice. Frontiers in Neuroscience. 10: 45. PMID 26973442 DOI: 10.3389/Fnins.2016.00045 |
0.733 |
|
2016 |
Brendel M, Reinisch V, Kalinowski E, Levin J, Delker A, Därr S, Pogarell O, Förster S, Bartenstein P, Rominger A, Alzheimer's Disease Neuroimaging Initiative. Hypometabolism in Brain of Cognitively Normal Patients with Depressive Symptoms is Accompanied by Atrophy-Related Partial Volume Effects. Current Alzheimer Research. 13: 475-86. PMID 26971944 DOI: 10.2174/1567205013666160314143922 |
0.524 |
|
2016 |
Suárez-Calvet M, Kleinberger G, Araque Caballero MÁ, Brendel M, Rominger A, Alcolea D, Fortea J, Lleó A, Blesa R, Gispert JD, Sánchez-Valle R, Antonell A, Rami L, Molinuevo JL, Brosseron F, et al. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers. Embo Molecular Medicine. PMID 26941262 DOI: 10.15252/Emmm.201506123 |
0.445 |
|
2016 |
Brendel M, Jaworska A, Probst F, Overhoff F, Korzhova V, Lindner S, Carlsen J, Bartenstein P, Harada R, Kudo Y, Haass C, van Leuven F, Okamura N, Herms J, Rominger A. microPET Imaging of Tau Pathology with [18F]-THK5117 in two Transgenic Mouse Models. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912432 DOI: 10.2967/Jnumed.115.163493 |
0.711 |
|
2016 |
Brendel M, Probst F, Jaworska A, Overhoff F, Korzhova V, Albert N, Beck R, Lindner S, Gildehaus FJ, Baumann K, Bartenstein P, Kleinberger G, Haass C, Herms J, Rominger A. Glial Activation and Glucose Metabolism in a Transgenic Amyloid Mouse Model: A Triple Tracer PET Study. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 26912428 DOI: 10.2967/Jnumed.115.167858 |
0.784 |
|
2016 |
Becker-Bense S, Stephan T, Albert N, Brendel M, Unterrainer M, Xiong G, Mille E, Habs M, Herz M, Schwaiger M, Dieterich M, Bartenstein P. EP 30. Hybrid-H215O-PET-fMRI measures during galvanic vestibular stimulation Clinical Neurophysiology. 127: e247-e248. DOI: 10.1016/j.clinph.2016.05.085 |
0.64 |
|
2015 |
Albert NL, Winkelmann I, Suchorska B, Wenter V, Schmid-Tannwald C, Mille E, Todica A, Brendel M, Tonn JC, Bartenstein P, la Fougère C. Early static (18)F-FET-PET scans have a higher accuracy for glioma grading than the standard 20-40 min scans. European Journal of Nuclear Medicine and Molecular Imaging. PMID 26666239 DOI: 10.1007/s00259-015-3276-2 |
0.718 |
|
2015 |
Araque Caballero MÁ, Brendel M, Delker A, Ren J, Rominger A, Bartenstein P, Dichgans M, Weiner MW, Ewers M. Mapping 3-year changes in gray matter and metabolism in Aβ-positive nondemented subjects. Neurobiology of Aging. 36: 2913-24. PMID 26476234 DOI: 10.1016/J.Neurobiolaging.2015.08.007 |
0.538 |
|
2015 |
Brendel M, Jaworska A, Herms J, Trambauer J, Rötzer C, Gildehaus FJ, Carlsen J, Cumming P, Bylund J, Luebbers T, Bartenstein P, Steiner H, Haass C, Baumann K, Rominger A. Monitoring of chronic γ-secretase modulator treatment by serial amyloid-PET. Molecular Psychiatry. 20: 1141. PMID 26401838 DOI: 10.1038/mp.2015.146 |
0.704 |
|
2015 |
Rominger A, Cumming P, Brendel M, Xiong G, Zach C, Karch S, Tatsch K, Bartenstein P, la Fougère C, Koch W, Pogarell O. Altered serotonin and dopamine transporter availabilities in brain of depressed patients upon treatment with escitalopram: A [123 I]β-CIT SPECT study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 873-81. PMID 25819144 DOI: 10.1016/J.Euroneuro.2014.12.010 |
0.353 |
|
2015 |
Brendel M, Jaworska A, Grießinger E, Rötzer C, Burgold S, Gildehaus FJ, Carlsen J, Cumming P, Baumann K, Haass C, Steiner H, Bartenstein P, Herms J, Rominger A. Cross-sectional comparison of small animal [18F]-florbetaben amyloid-PET between transgenic AD mouse models. Plos One. 10: e0116678. PMID 25706990 DOI: 10.1371/Journal.Pone.0116678 |
0.722 |
|
2015 |
Brendel M, Pogarell O, Xiong G, Delker A, Bartenstein P, Rominger A. Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients. European Journal of Nuclear Medicine and Molecular Imaging. 42: 716-24. PMID 25631614 DOI: 10.1007/s00259-014-2975-4 |
0.429 |
|
2015 |
Brendel M, Högenauer M, Delker A, Sauerbeck J, Bartenstein P, Seibyl J, Rominger A. Improved longitudinal [(18)F]-AV45 amyloid PET by white matter reference and VOI-based partial volume effect correction. Neuroimage. 108: 450-9. PMID 25482269 DOI: 10.1016/j.neuroimage.2014.11.055 |
0.564 |
|
2015 |
Brendel M, Jaworska A, Herms J, Trambauer J, Rötzer C, Gildehaus FJ, Carlsen J, Cumming P, Bylund J, Luebbers T, Bartenstein P, Steiner H, Haass C, Baumann K, Rominger A. Amyloid-PET predicts inhibition of de novo plaque formation upon chronic γ-secretase modulator treatment Molecular Psychiatry. DOI: 10.1038/mp.2015.74 |
0.688 |
|
2015 |
Simon-Vermot L, Zhang Y, Caballero MÁA, Gesierich B, Kambeitz-Ilankovic L, Brendel M, Rominger A, Bartenstein P, Duering M, Ewers M. Temporo-parietal hypometabolism is associated with reduced functional connectivity of the default mode network in prodromal Alzheimer's disease Alzheimers & Dementia. 11: 542. DOI: 10.1016/J.Jalz.2015.06.684 |
0.348 |
|
2014 |
Ewers M, Brendel M, Rizk-Jackson A, Rominger A, Bartenstein P, Schuff N, Weiner MW. Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects. Neuroimage. Clinical. 4: 45-52. PMID 24286024 DOI: 10.1016/J.Nicl.2013.10.018 |
0.565 |
|
2014 |
Brendel M, Delker A, Rötzer C, Böning G, Carlsen J, Cyran C, Mille E, Gildehaus FJ, Cumming P, Baumann K, Steiner H, Haass C, Herms J, Bartenstein P, Rominger A. Impact of partial volume effect correction on cerebral β-amyloid imaging in APP-Swe mice using [(18)F]-florbetaben PET. Neuroimage. 84: 843-53. PMID 24055703 DOI: 10.1016/J.Neuroimage.2013.09.017 |
0.756 |
|
2014 |
Araque Caballero MÁ, Brendel M, Delker A, Ren J, Rominger A, Bartenstein P, Weiner MW, Ewers M. IC-P-114: MAPPING 3-YEAR RATES OF DECLINE IN JOINTLY ASSESSED GRAY MATTER VOLUME AND FDG-PET IN AB+ NON-DEMENTED SUBJECTS Alzheimer's & Dementia. 10: P63-P64. DOI: 10.1016/j.jalz.2014.05.120 |
0.456 |
|
2014 |
Caballero MÁA, Brendel M, Delker A, Ren J, Rominger A, Bartenstein P, Weiner MW, Ewers M. O3-03-03: MAPPING 3-YEAR RATES OF DECLINE IN JOINTLY ASSESSED GRAY MATTER VOLUME AND FDG-PET IN Aβ+ NON-DEMENTED SUBJECTS Alzheimer's & Dementia. 10: P212-P212. DOI: 10.1016/J.Jalz.2014.04.282 |
0.477 |
|
2014 |
Rominger A, Brendel M, Rötzer C, Gildehaus F, Baumann K, Haass C, Steiner H, Herms J, Bartenstein P. Monitoring Of Long-Term Gamma Secretase Modulation Treatment In App-Swe Mice By Means Of [18F]-Florbetaben Pet Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.04.113 |
0.718 |
|
2013 |
Rominger A, Brendel M, Burgold S, Keppler K, Baumann K, Xiong G, Mille E, Gildehaus FJ, Carlsen J, Schlichtiger J, Niedermoser S, Wängler B, Cumming P, Steiner H, Herms J, et al. Longitudinal assessment of cerebral β-amyloid deposition in mice overexpressing Swedish mutant β-amyloid precursor protein using 18F-florbetaben PET. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 1127-34. PMID 23729696 DOI: 10.2967/Jnumed.112.114660 |
0.754 |
|
2013 |
Brendel M, Böning G, Delker A, Rötzer C, Gildehaus F, Baumann K, Steiner H, Haass C, Herms J, Bartenstein P, Rominger A. PET imaging using [18F]florbetaben in Alzheimer's disease mouse models Alzheimers & Dementia. 9: 29. DOI: 10.1016/J.Jalz.2013.05.041 |
0.753 |
|
2012 |
Rominger A, Brendel M, Baumann K, Gildehaus F, Niedermoser S, Wängler B, Burgold S, Herms J, Cumming P, Steiner H, Haass C, Bartenstein P. Longitudinal imaging of cerebral beta-amyloid in APP-swe mice using [18F]florbetaben PET Alzheimers & Dementia. 8. DOI: 10.1016/J.Jalz.2012.05.411 |
0.733 |
|
2012 |
Rominger A, Brendel M, Baumann K, Gildehaus F, Niedermoser S, Wängler B, Burgold S, Herms J, Cumming P, Steiner H, Haass C, Bartenstein P. Longitudinal imaging of cerebral Aβ in APP-Swe mice using [18F]florbetaben PET Alzheimers & Dementia. 8: 11. DOI: 10.1016/J.Jalz.2012.05.033 |
0.755 |
|
Show low-probability matches. |